Physical Address

304 North Cardinal St.
Dorchester Center, MA 02124

Category Dermatology

FDA Approves Fifth Ustekinumab Biosimilar

The US Food and Drug Administration (FDA) has approved ustekinumab-srlf (Imuldosa) as a biosimilar to ustekinumab (Stelara) for the treatment of multiple inflammatory conditions. This is the fifth ustekinumab biosimilar approved by the FDA, and it is expected to become…

Trending now

FDA Approves Fifth Ustekinumab BiosimilareThekwini residents threaten rates boycottRescuers retrieve remains of all passengers in Brazil plane crash as families gather in Sao PauloNUS students paid to educate tourists on etiquette on campus, lead guided tours
en_USEnglish
en_USEnglish